Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 91

1.

Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine.

Porter KR, Ewing D, Chen L, Wu SJ, Hayes CG, Ferrari M, Teneza-Mora N, Raviprakash K.

Vaccine. 2012 Jan 5;30(2):336-41. doi: 10.1016/j.vaccine.2011.10.085. Epub 2011 Nov 12.

PMID:
22085548
2.

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial.

Beckett CG, Tjaden J, Burgess T, Danko JR, Tamminga C, Simmons M, Wu SJ, Sun P, Kochel T, Raviprakash K, Hayes CG, Porter KR.

Vaccine. 2011 Jan 29;29(5):960-8. doi: 10.1016/j.vaccine.2010.11.050. Epub 2010 Nov 25.

PMID:
21111785
4.

Early detection of dengue infections using cluster sampling around index cases.

Beckett CG, Kosasih H, Faisal I, Nurhayati, Tan R, Widjaja S, Listiyaningsih E, Ma'roef C, Wuryadi S, Bangs MJ, Samsi TK, Yuwono D, Hayes CG, Porter KR.

Am J Trop Med Hyg. 2005 Jun;72(6):777-82.

PMID:
15967759
5.
6.

Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies.

Lu Y, Raviprakash K, Leao IC, Chikhlikar PR, Ewing D, Anwar A, Chougnet C, Murphy G, Hayes CG, August TJ, Marques ET Jr.

Vaccine. 2003 May 16;21(17-18):2178-89.

PMID:
12706709
7.

Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever.

Kochel TJ, Watts DM, Halstead SB, Hayes CG, Espinoza A, Felices V, Caceda R, Bautista CT, Montoya Y, Douglas S, Russell KL.

Lancet. 2002 Jul 27;360(9329):310-2.

PMID:
12147378
8.

Synergistic neutralizing antibody response to a dengue virus type 2 DNA vaccine by incorporation of lysosome-associated membrane protein sequences and use of plasmid expressing GM-CSF.

Raviprakash K, Marques E, Ewing D, Lu Y, Phillips I, Porter KR, Kochel TJ, August TJ, Hayes CG, Murphy GS.

Virology. 2001 Nov 10;290(1):74-82.

9.

West Nile virus: Uganda, 1937, to New York City, 1999.

Hayes CG.

Ann N Y Acad Sci. 2001 Dec;951:25-37. Review.

PMID:
11797781
10.

Characterization of antibody responses to combinations of a dengue-2 DNA and dengue-2 recombinant subunit vaccine.

Simmons M, Murphy GS, Kochel T, Raviprakash K, Hayes CG.

Am J Trop Med Hyg. 2001 Nov;65(5):420-6.

PMID:
11716093
11.

Development and evaluation of serotype- and group-specific fluorogenic reverse transcriptase PCR (TaqMan) assays for dengue virus.

Callahan JD, Wu SJ, Dion-Schultz A, Mangold BE, Peruski LF, Watts DM, Porter KR, Murphy GR, Suharyono W, King CC, Hayes CG, Temenak JJ.

J Clin Microbiol. 2001 Nov;39(11):4119-24.

12.

Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission.

Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, Kanesa-Thasan N, Hayes CG, Watts DM.

Am J Trop Med Hyg. 2001 Sep;65(3):180-3.

PMID:
11561700
13.

Short report: Antibody responses of mice immunized with a tetravalent dengue recombinant protein subunit vaccine.

Simmons M, Murphy GS, Hayes CG.

Am J Trop Med Hyg. 2001 Aug;65(2):159-61.

PMID:
11508393
14.

Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.

Wu SJ, Lee EM, Putvatana R, Shurtliff RN, Porter KR, Suharyono W, Watts DM, King CC, Murphy GS, Hayes CG, Romano JW.

J Clin Microbiol. 2001 Aug;39(8):2794-8.

15.

Hepatitis E virus DNA vaccine elicits immunologic memory in mice.

He J, Hayes CG, Binn LN, Seriwatana J, Vaughn DW, Kuschner RA, Innis BL.

J Biomed Sci. 2001 Mar-Apr;8(2):223-6.

PMID:
11287754
16.

Molecular characterization of a hepatitis E virus isolate from Namibia.

He J, Binn LN, Tsarev SA, Hayes CG, Frean JA, Isaacson M, Innis BL.

J Biomed Sci. 2000 Jul-Aug;7(4):334-8.

PMID:
10895057
17.

Human skin Langerhans cells are targets of dengue virus infection.

Wu SJ, Grouard-Vogel G, Sun W, Mascola JR, Brachtel E, Putvatana R, Louder MK, Filgueira L, Marovich MA, Wong HK, Blauvelt A, Murphy GS, Robb ML, Innes BL, Birx DL, Hayes CG, Frankel SS.

Nat Med. 2000 Jul;6(7):816-20.

PMID:
10888933
18.

Dengue virus type 1 DNA vaccine induces protective immune responses in rhesus macaques.

Raviprakash K, Porter KR, Kochel TJ, Ewing D, Simmons M, Phillips I, Murphy GS, Weiss WR, Hayes CG.

J Gen Virol. 2000 Jul;81(Pt 7):1659-67.

PMID:
10859370
19.

A dengue virus serotype-1 DNA vaccine induces virus neutralizing antibodies and provides protection from viral challenge in Aotus monkeys.

Kochel TJ, Raviprakash K, Hayes CG, Watts DM, Russell KL, Gozalo AS, Phillips IA, Ewing DF, Murphy GS, Porter KR.

Vaccine. 2000 Jul 15;18(27):3166-73.

PMID:
10856796
20.

Construction of a full length infectious clone for dengue-1 virus Western Pacific,74 strain.

Puri B, Polo S, Hayes CG, Falgout B.

Virus Genes. 2000;20(1):57-63.

PMID:
10766307
21.

Immunogenicity of dengue virus type 1 DNA vaccines expressing truncated and full length envelope protein.

Raviprakash K, Kochel TJ, Ewing D, Simmons M, Phillips I, Hayes CG, Porter KR.

Vaccine. 2000 May 8;18(22):2426-34.

PMID:
10738100
22.

Comparison of two rapid diagnostic assays for detection of immunoglobulin M antibodies to dengue virus.

Wu SJ, Paxton H, Hanson B, Kung CG, Chen TB, Rossi C, Vaughn DW, Murphy GS, Hayes CG.

Clin Diagn Lab Immunol. 2000 Jan;7(1):106-10.

23.

Failure of secondary infection with American genotype dengue 2 to cause dengue haemorrhagic fever.

Watts DM, Porter KR, Putvatana P, Vasquez B, Calampa C, Hayes CG, Halstead SB.

Lancet. 1999 Oct 23;354(9188):1431-4.

PMID:
10543670
24.

A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

Graham RR, Juffrie M, Tan R, Hayes CG, Laksono I, Ma'roef C, Erlin, Sutaryo, Porter KR, Halstead SB.

Am J Trop Med Hyg. 1999 Sep;61(3):412-9.

PMID:
10497982
25.

Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America.

Tesh RB, Watts DM, Russell KL, Damodaran C, Calampa C, Cabezas C, Ramirez G, Vasquez B, Hayes CG, Rossi CA, Powers AM, Hice CL, Chandler LJ, Cropp BC, Karabatsos N, Roehrig JT, Gubler DJ.

Clin Infect Dis. 1999 Jan;28(1):67-73.

PMID:
10028074
26.

Complete nucleotide sequence analysis of a Western Pacific dengue-1 virus strain.

Puri B, Nelson W, Porter KR, Henchal EA, Hayes CG.

Virus Genes. 1998;17(1):85-8.

PMID:
9778791
27.

Immune response against the exp-1 protein of Plasmodium falciparum results in antibodies that cross-react with human T-cell lymphotropic virus type 1 proteins.

Porter KR, Aguiar J, Richards A, Sandjaya B, Ignatias H, Hadiputranto H, Ridley RG, Takacs B, Wignall FS, Hoffman SL, Hayes CG.

Clin Diagn Lab Immunol. 1998 Sep;5(5):721-4.

28.

Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses.

Porter KR, Kochel TJ, Wu SJ, Raviprakash K, Phillips I, Hayes CG.

Arch Virol. 1998;143(5):997-1003.

PMID:
9645204
29.
30.

Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.

Simmons M, Porter KR, Escamilla J, Graham R, Watts DM, Eckels KH, Hayes CG.

Am J Trop Med Hyg. 1998 Feb;58(2):144-51.

PMID:
9502595
31.

Conversion of dengue virus replicative form RNA (RF) to replicative intermediate (RI) by nonstructural proteins NS-5 and NS-3.

Raviprakash K, Sinha M, Hayes CG, Porter KR.

Am J Trop Med Hyg. 1998 Jan;58(1):90-5.

PMID:
9452298
32.

Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region.

Watts DM, Callahan J, Rossi C, Oberste MS, Roehrig JT, Wooster MT, Smith JF, Cropp CB, Gentrau EM, Karabatsos N, G├╝bler D, Hayes CG.

Am J Trop Med Hyg. 1998 Jan;58(1):35-40.

PMID:
9452289
33.

Molecular analysis of dengue virus attenuation after serial passage in primary dog kidney cells.

Puri B, Nelson WM, Henchal EA, Hoke CH, Eckels KH, Dubois DR, Porter KR, Hayes CG.

J Gen Virol. 1997 Sep;78 ( Pt 9):2287-91.

PMID:
9292016
34.

Evaluation of a dipstick enzyme-linked immunosorbent assay for detection of antibodies to dengue virus.

Wu SJ, Hanson B, Paxton H, Nisalak A, Vaughn DW, Rossi C, Henchal EA, Porter KR, Watts DM, Hayes CG.

Clin Diagn Lab Immunol. 1997 Jul;4(4):452-7.

35.

Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru.

Watts DM, Lavera V, Callahan J, Rossi C, Oberste MS, Roehrig JT, Cropp CB, Karabatsos N, Smith JF, Gubler DJ, Wooster MT, Nelson WM, Hayes CG.

Am J Trop Med Hyg. 1997 Jun;56(6):661-7.

PMID:
9230800
36.
37.

Oropouche virus transmission in the Amazon River basin of Peru.

Watts DM, Phillips I, Callahan JD, Griebenow W, Hyams KC, Hayes CG.

Am J Trop Med Hyg. 1997 Feb;56(2):148-52.

PMID:
9080872
38.

Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia.

Porter KR, Mascola JR, Hupudio H, Ewing D, VanCott TC, Anthony RL, Corwin AL, Widodo S, Ertono S, McCutchan FE, Burke DS, Hayes CG, Wignall FS, Graham RR.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):1-6.

PMID:
8989203
39.

The epidemiology of dengue virus infection among urban, jungle, and rural populations in the Amazon region of Peru.

Hayes CG, Phillips IA, Callahan JD, Griebenow WF, Hyams KC, Wu SJ, Watts DM.

Am J Trop Med Hyg. 1996 Oct;55(4):459-63.

PMID:
8916809
40.

Longitudinal studies of children born to HIV-1 antibody positive Filipino commercial sex workers (CSW): diagnostic dilemmas.

Manaloto CR, Caringal LT, Santiago EG, Basaca-Sevilla V, Perrault JG, Hayes CG, Anthony RL.

Int J STD AIDS. 1996 May-Jun;7(3):212-20.

PMID:
8799785
41.

Hepatitis E virus infection in Peru.

Hyams KC, Yarbough PO, Gray S, Callahan J, Gotuzzo E, Gutierrez J, Vasquez PB, Hayes CG, Watts DM.

Clin Infect Dis. 1996 Apr;22(4):719-20. No abstract available.

PMID:
8729219
42.

Dengue fever in U.S. troops during Operation Restore Hope, Somalia, 1992-1993.

Sharp TW, Wallace MR, Hayes CG, Sanchez JL, DeFraites RF, Arthur RR, Thornton SA, Batchelor RA, Rozmajzl PJ, Hanson RK, et al.

Am J Trop Med Hyg. 1995 Jul;53(1):89-94.

PMID:
7625541
43.

Evaluation of the severe combined immunodeficient (SCID) mouse as an animal model for dengue viral infection.

Wu SJ, Hayes CG, Dubois DR, Windheuser MG, Kang YH, Watts DM, Sieckmann DG.

Am J Trop Med Hyg. 1995 May;52(5):468-76.

PMID:
7771614
44.
45.

Natural history of HIV infection in Filipino female commercial sex workers.

Manaloto CR, Perrault JG, Caringal LT, Santiago EG, Wignall FS, Gonzales VL, Anthony RL, Hayes CG.

J Acquir Immune Defic Syndr. 1994 Nov;7(11):1157-68.

PMID:
7932083
46.

Respiratory hospital admissions and summertime haze air pollution in Toronto, Ontario: consideration of the role of acid aerosols.

Thurston GD, Ito K, Hayes CG, Bates DV, Lippmann M.

Environ Res. 1994 May;65(2):271-90.

PMID:
8187742
47.

Isolation of HIV-1 from Filipino commercial sex workers (CSWs).

Torres CA, Hayes CG, Manaloto CR, Gonzales VL, Anthony RL.

Southeast Asian J Trop Med Public Health. 1994 Mar;25(1):96-101.

PMID:
7825033
48.

A rapid method for detection and identification of flaviviruses by polymerase chain reaction and nucleic acid hybridization.

Puri B, Henchal EA, Burans J, Porter KR, Nelson W, Watts DM, Hayes CG.

Arch Virol. 1994;134(1-2):29-37.

PMID:
8279959
49.

Evidence for anti-Plasmodium falciparum antibodies that cross-react with human T-lymphotropic virus type I proteins in a population in Irian Jaya, Indonesia.

Porter KR, Liang L, Long GW, Bangs MJ, Anthony R, Andersen EM, Hayes CG.

Clin Diagn Lab Immunol. 1994 Jan;1(1):11-5.

50.

Cytokine concentrations in cerebrospinal fluid in flavivirus infections.

Kuno G, Hayes CG, Chen WJ.

Southeast Asian J Trop Med Public Health. 1993 Dec;24(4):781-2. No abstract available.

PMID:
7939960

Supplemental Content

Loading ...
Support Center